Soleus Capital is an investment adviser with its principal place of business located in Greenwich, CT. Soleus Capital was formed in 2017 and began operations in 2018. The Adviser is privately held by its general partner, Soleus GP, LLC, which is controlled by Guy B. Levy. Soleus Capital provides investment advisory services to privately offered pooled investment funds (“Funds”) and may, in the future, provide advisory services to managed accounts (collectively with the Funds, the “Clients”). Soleus Capital manages each Client’s assets on a fully discretionary basis in accordance with the investment objectives outlined in the relevant Offering Documents (defined below) and/or investment management agreement for each Client. Soleus Capital manages each Client’s portfolio in accordance with a fundamentals-driven strategy. Soleus Capital’s primary investment strategy seeks superior risk-adjusted returns over time by investing in the healthcare sector (including biotechnology, medical technology, life science tools, healthcare services and other related subsectors). Soleus Capital currently manages hedge funds, private equity funds, and special purpose vehicles. Soleus Capital also anticipates possibly managing one or more credit strategies in the future, including a strategy that would seek to invest principally in loans, asset-backed securities, convertible bonds, preferred equity, and other debt and debt-related instruments, primarily issued by small- and mid-cap publicly traded companies and privately held growth-stage companies in the healthcare sector. The hedge funds generally employ a long/short strategy and primarily invest in equity securities of U.S. and non-U.S. publicly traded healthcare companies. The private equity funds

generally seek to invest in middle-to-late stage investments in anticipation of a potential near-term initial public offering, private investments in public equities, and other investible, illiquid securities, including convertible equity and debt securities. With respect to the Funds, Soleus Capital manages each Fund in accordance with the relevant limited partnership agreement, investment management agreement, offering memorandum , or other applicable Fund documentation (collectively, “Offering Documents”), where applicable. Any Fund restrictions on investments are set forth in each respective Fund’s Offering Documents. Soleus Capital does not tailor its investment advice to the individual investors in each Fund that it manages. As such, investors cannot impose restrictions on the types of investments made through the Funds. Subject to applicable law and each Fund’s Offering Documents, the general partners of the Funds have entered into side letter arrangements with certain investors and may continue to do so in the future. Certain side letters have the effect of altering or supplementing the terms of such investors’ investments in a Fund, including reductions of fees. In the future, side letters could provide certain investors additional access to portfolio information or rights to make withdrawals. To the extent such side letter arrangements exist, certain investors in a Fund will receive more favorable fees, access to information, liquidity, or other terms. Soleus Capital does not participate in any wrap fee programs. As of December 31, 2023, Soleus Capital managed approximately $1,979,290,655 of Client assets on a discretionary basis. Soleus does not manage any Client assets on a non-discretionary basis.